Adma Biologics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Adma Biologics

Access the complete profile.

Adma Biologics Fast Facts

Revenue	Over $500 million    See Exact Annual Revenue
Employees	500 - 1,000Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing 5417 Scientific Research & Development Services
Address	5800 Park Of Commerce Blvd Nw Boca Raton, FL 33487

Note: Revenues for privately held companies are statistical evaluations.


Adma Biologics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Adma Biologics's annual revenues are Over $500 million (see exact revenue data)
• What industry is the company in?
  • Adma Biologics is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Adma Biologics Annual Revenue and Growth Rate

Adma Biologics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	Over $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Adma Biologics's revenues are gauged from an analysis of company filings.

Adma Biologics's Income Statement (based on Industry Averages)

Adma Biologics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Adma Biologics is developing and marketing. Adma Biologics doesn't have any recent trademark applications, indicating Adma Biologics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
ADVANTAGE IG Financial administration of medication reimbursement programs and services; providing financial consultancy services and assistance for health care; providing information on health insurance benefits and patient financial assistance	03/24/2021
ADVIGA Pharmaceutical preparations, namely, IVIG (Intravenous Immunoglobulin)	04/25/2016
ASCENIV Pharmaceutical preparations, namely, IVIG (Intravenous Immunoglobulin)	04/25/2016

See all trademarks and details in the Full Report.

Market Share of Adma Biologics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Adma Biologics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Adma Biologics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BPC PLASMA	Boca Raton, FL	100
ADMA BIOLOGICS	Boca Raton, FL	41
LGM PHARMA	Boca Raton, FL	16
KRS GLOBAL BIOTECHNOLOGY	Boca Raton, FL	7
HOT SHOTS NUCLEAR MEDICINE	Boca Raton, FL	4
MEDTIS CONSULTING	Wellington, FL	2

Future Competition: Adma Biologics's Fastest Growing Competitors

These companies are in the same general field as Adma Biologics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)